DI-B4
DI-B4 is an anti-CD19 monoclonal antibody that can bind to CD19 on the surface of B cells and has anti-tumor activity[1].
Product Specifications
UNSPSC
12352203
Target
CD19
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[2H]I([B])B([B])[B]
References & Citations
[1]A trial of a monoclonal antibody called DI-B4 for low grade B cell lymphoma and chronic lymphocytic leukaemia. Cancer research UK.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
More Discoveries
Explore Other Products
Browse additional items from our catalog
C1036-79E-PE 200 µL
CAMKK2, NT (G67) (Calcium/Calmodulin-dependent Protein Kinase Kinase 2, CaM-kinase Kinase 2, CaM-KK 2, CaMKK 2, Calcium/Calmodulin-dependent Protein Kinase Kinase beta, CaM-kinase Kinase beta, CaM-KK beta, CaMKK beta, CAMKKB, KIAA0787) (PE) discontinued
Sign In for Pricing
View Details